Tau silencing gene therapy VY1706 robustly reduced tau mRNA levels, with broad distribution, and was well-tolerated in NHP ...

Teddi Mellencamp was diagnosed with melanoma in 2022. Since then, she's had multiple biopsies, surgeries and the cancer has ...

Longeveron (LGVN) announced the publication in Nature Medicine of results from the CLEAR MIND Phase 2a clinical trial evaluating laromestrocel ...

Results of positron emission tomography (PET) trial and second multiple ascending dose (MAD-2) trial support RAP-219's transformative potential ...

PSMA PET/CT trial will scan up to 1000 men in the UKA new kind of scan that could be key to improving the treatment of high-risk prostate cancer is ...

Israel-based radiopharma company Isotopia has launched Isoprotrace in Germany, supported by distribution partner DSD Pharma.

DSD Pharma, a trusted pharmaceutical distributor in Germany, will serve as the exclusive partner for the distribution of Isoprotrace� throughout the country, ensuring efficient, consistent delivery to ...

FDG PET-derived imaging biomarkers of airway inflammation and their clinical associations in patients with non-small cell ...

The global internal radiation therapy market is set for significant expansion, with revenue expected to reach USD 1.1 billion by 2024 and a compound annual growth rate (CAGR) of 6.2% projected between ...

The global nuclear medical equipment market is poised for steady growth, expanding at a CAGR of 4.1% from 2022 to 2032. Market projections indicate that the sector will increase from USD 2.3 billion ...

Isotopia, a leading developer of innovative radio-pharmaceuticals, has officially launched Isoprotrace® in Germany. DSD ...

Scientists at St. Jude Children’s Research Hospital have used positron emission tomography (PET) with edaravone, a drug used ...